Insider Transactions Reported by 17 Insiders of Neumora Therapeutics, Inc.

Symbol
NMRA on Nasdaq
Location
Watertown, MA

Insiders trading volume in the past year

Neumora Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
AMGEN INC 10%+ Owner $423,716,463 19 Sep 2023
FMR LLC Other* $67,379,749 19 Sep 2023
Kristina Burow Director, 10%+ Owner $66,466,963 +$4,999,977 +8.1% 27 Oct 2025
ARCH Venture Partners XII, LLC 10%+ Owner $66,380,119 +$4,999,977 +8.1% 27 Oct 2025
ARCH Venture Partners X, LLC 10%+ Owner $66,380,119 +$4,999,977 +8.1% 27 Oct 2025
Paul L Berns Title: Chief Executive Officer and Chairman of the Board, Director $26,224,179 -$34,459 -0.13% 17 Feb 2026
Gosebruch Henry O. President & CEO, Director $7,065,720 14 Feb 2024
Carol Y. Suh Chief Operating Officer $4,488,595 14 Feb 2024
Robert A. Lenz Head of R&D $516,616 18 Feb 2025
Joshua Pinto President $514,682 -$21,093 -3.9% 17 Feb 2026
Matthew K. Fust Director $342,395 28 May 2025
Daljit Singh Aurora Title: Chief Operating and Development Officer $294,247 -$328,942 -53% 17 Feb 2026
Maykin Ho Director $240,798 28 May 2025
David Piacquad Director $240,798 28 May 2025
Alaa Halawa Director $240,798 28 May 2025
Michael Lee Milligan Title: Chief Financial Officer & Principal Accounting Officer $74,986 -$5,119 -6.4% 17 Feb 2026
Jason Duncan Title: Chief Legal and Administrative Officer 08 Jan 2026

Recent Insider Transactions by Companies or Individuals for Neumora Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.